179 related articles for article (PubMed ID: 27764235)
21. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia.
Quijano CA; Moore D; Arthur D; Feusner J; Winter SS; Pallavicini MG
Leukemia; 1997 Sep; 11(9):1508-15. PubMed ID: 9305606
[TBL] [Abstract][Full Text] [Related]
22. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.
Giannoni F; Hardee CL; Wherley J; Gschweng E; Senadheera S; Kaufman ML; Chan R; Bahner I; Gersuk V; Wang X; Gjertson D; Baltimore D; Witte ON; Economou JS; Ribas A; Kohn DB
Mol Ther; 2013 May; 21(5):1044-54. PubMed ID: 23380815
[TBL] [Abstract][Full Text] [Related]
23. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
[TBL] [Abstract][Full Text] [Related]
24. Divergent effects of supraphysiologic Notch signals on leukemia stem cells and hematopoietic stem cells.
Chiang MY; Shestova O; Xu L; Aster JC; Pear WS
Blood; 2013 Feb; 121(6):905-17. PubMed ID: 23115273
[TBL] [Abstract][Full Text] [Related]
25. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.
Zuurbier L; Gutierrez A; Mullighan CG; Canté-Barrett K; Gevaert AO; de Rooi J; Li Y; Smits WK; Buijs-Gladdines JG; Sonneveld E; Look AT; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2014 Jan; 99(1):94-102. PubMed ID: 23975177
[TBL] [Abstract][Full Text] [Related]
26. Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential.
Weerkamp F; Baert MR; Brugman MH; Dik WA; de Haas EF; Visser TP; de Groot CJ; Wagemaker G; van Dongen JJ; Staal FJ
Blood; 2006 Apr; 107(8):3131-7. PubMed ID: 16384926
[TBL] [Abstract][Full Text] [Related]
27. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome.
Dakka N; Bellaoui H; Bouzid N; Khattab M; Bakri Y; Benjouad A
Pediatr Hematol Oncol; 2009 Jun; 26(4):216-31. PubMed ID: 19437324
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
29. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
31. MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
Stroopinsky D; Rosenblatt J; Ito K; Mills H; Yin L; Rajabi H; Vasir B; Kufe T; Luptakova K; Arnason J; Nardella C; Levine JD; Joyce RM; Galinsky I; Reiter Y; Stone RM; Pandolfi PP; Kufe D; Avigan D
Cancer Res; 2013 Sep; 73(17):5569-79. PubMed ID: 23867470
[TBL] [Abstract][Full Text] [Related]
32. Significance of CD99 expression in T-lineage acute lymphoblastic leukemia.
Enein AA; Rahman HA; Sharkawy NE; Elhamid SA; Abbas SM; Abdelfaatah R; Khalil M; Fathalla LA
Cancer Biomark; 2016 Mar; 17(2):117-23. PubMed ID: 27002769
[TBL] [Abstract][Full Text] [Related]
33. Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Tembhare PR; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Panda D; Patkar NV; Narula G; Girase K; Verma S; Sanyal M; Sriram HN; Banavali S; Gujral S; Subramanian PG
Cytometry B Clin Cytom; 2021 Jul; 100(4):421-433. PubMed ID: 32812702
[TBL] [Abstract][Full Text] [Related]
34. CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients.
Björklund E; Gruber A; Mazur J; Mårtensson A; Hansson M; Porwit A
Int J Hematol; 2009 Oct; 90(3):292-302. PubMed ID: 19728029
[TBL] [Abstract][Full Text] [Related]
35. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Dworzak MN; Fröschl G; Printz D; Zen LD; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig WD; Gadner H
Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
[TBL] [Abstract][Full Text] [Related]
36. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma/leukemia].
Yu B; Du JR; Xie JL; Yu R; Zheng XD; Zhu H; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):452-7. PubMed ID: 21055173
[TBL] [Abstract][Full Text] [Related]
38. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.
Ma W; Gutierrez A; Goff DJ; Geron I; Sadarangani A; Jamieson CA; Court AC; Shih AY; Jiang Q; Wu CC; Li K; Smith KM; Crews LA; Gibson NW; Deichaite I; Morris SR; Wei P; Carson DA; Look AT; Jamieson CH
PLoS One; 2012; 7(6):e39725. PubMed ID: 22768113
[TBL] [Abstract][Full Text] [Related]
39. Death induction by CD99 ligation in TEL/AML1-positive acute lymphoblastic leukemia and normal B cell precursors.
Husak Z; Printz D; Schumich A; Pötschger U; Dworzak MN
J Leukoc Biol; 2010 Aug; 88(2):405-12. PubMed ID: 20453109
[TBL] [Abstract][Full Text] [Related]
40. Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
Diamanti P; Cox CV; Moppett JP; Blair A
Blood; 2013 Feb; 121(8):1384-93. PubMed ID: 23264600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
